Delivery Order SPE2DB22D9367-SPE2DB25FSZ01
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,146.79 by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Jakafi 5 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis leveraging its established...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Jakafi 15 mg tablets (60-count units) with a ceiling value of $11,999.80. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and was awarded on August 1, 2025. This award utilizes no set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 31, 2025, by the Defense Logistics Agency for the supply of Jakafi 10 mg tablets (60-count unit). This firm fixed-price delivery order, valued at $24,231.30, represents a single shipment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The contract includes no set-aside designation, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12.0K on July 22, 2025, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), the Department of Defense's combat support agency responsible for logistics and supply chain management. The award carries an ultimate completion date of July 23, 2025, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $24,293.60 on July 28, 2025, for the supply of Jakafi 5 mg tablets (60-count units). The contract, which carries no set-aside designation, is issued under DMS's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million through November 2026. This delivery order will be...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,115.65 by the Defense Logistics Agency on July 21, 2025, for the supply of Jakafi 10 mg tablets (60-count packages). The contract utilizes a firm fixed-price structure with no set-aside designation and carries an ultimate completion date of July 22, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing single-award...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The award carries no set-aside designation and represents a single delivery order issued under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $24,231.30 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order is expected to be completed by July 31, 2025, and represents a continuation of the company's significant role as a federal pharmaceutical supplier. The award carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $24,293.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $24,231.30 for 60 tablets of Jakafi 10 mg on July 18, 2025. The contract, which has no set-aside designation, is set to be completed by July 21, 2025, with performance at the awardee's Park Ridge location. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSZ01Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 28, 2025, by the Defense Logistics Agency (DLA) for the supply of Jakafi 15 mg tablets (60 count). This $24.0K firm fixed-price delivery order, which was completed on July 29, 2025, carries no set-aside designation and represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The company leverages its position as a certified woman-owned small business to compete effectively in federal procurement while maintaining an extensive portfolio of pharmaceutical product deliveries to military and federal healthcare facilities nationwide. This delivery order is issued under the DLA's SPE2DB program, which establishes a $500.0M single-award indefinite delivery contract vehicle through November 2026 that enables the agency to procure comprehensive pharmaceutical supplies for Department of Defense healthcare sites worldwide. Jakafi (ruxolitinib), a prescription medication, is among the diverse range of branded and generic drugs, biologics, and medical consumables that DMS Pharmaceutical Group supplies through this contract vehicle. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group continues to demonstrate its capability to provide direct distribution of specialized prescription medications supporting medical supply needs across military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.0k | 7/28/25 |